Varenicline Kit
NDC Package 75834-336-24

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Varenicline kits is varenicline tablets are indicated for use as an aid to smoking-cessation treatment. This formulation utilizes a kit delivery system. Marketed by Nivagen Pharmaceuticals Inc., this product is identified by NDC 75834-336 and is authorized under FDA application ANDA217115.

Identification & Billing

NDC Package Code
75834-336-24
Package Description
2 BOX in 1 KIT / 1 KIT in 1 BOX * 1 BLISTER PACK in 1 BOX (75834-334-25) / 11 TABLET, FILM COATED in 1 BLISTER PACK * 3 BLISTER PACK in 1 BOX (75834-335-26) / 14 TABLET, FILM COATED in 1 BLISTER PACK
Product Code
75834-336
11-Digit Billing Format
75834033624
RxNorm Crosswalk
  • RxCUI: 636671 - varenicline 0.5 MG Oral Tablet
  • RxCUI: 636671 - varenicline 0.5 MG (as varenicline tartrate 0.85 MG) Oral Tablet
  • RxCUI: 636676 - varenicline 1 MG Oral Tablet
  • RxCUI: 636676 - varenicline 1 MG (as varenicline tartrate 1.71 MG) Oral Tablet
  • RxCUI: 749289 - {11 (varenicline 0.5 MG Oral Tablet) / 42 (varenicline 1 MG Oral Tablet) } Pack

Clinical Specifications

Proprietary Name
Varenicline
Non-Proprietary Name
Varenicline
Dosage Form
Kit - A packaged collection of related material.
Usage Information
Varenicline tablets are indicated for use as an aid to smoking-cessation treatment.

Regulatory & Marketing

Labeler Name
Nivagen Pharmaceuticals Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA217115
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
03-02-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 75834-336-24 identifies a specific commercial package of 2 box in 1 kit / 1 kit in 1 box * 1 blister pack in 1 box (75834-334-25) / 11 tablet, film coated in 1 blister pack * 3 blister pack in 1 box (75834-335-26) / 14 tablet, film coated in 1 blister pack of Varenicline, a human prescription drug labeled by Nivagen Pharmaceuticals Inc.. This kit is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Nivagen Pharmaceuticals Inc. on March 02, 2026. The current certification is valid through December 31, 2027.

How is this Nivagen Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 75834033624. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
75834-336-24
11-Digit CMS (5-4-2)
75834-0336-24

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.